Opioids | Internet | Biotech Stock Review

Opioids

ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA, yet the Psychedelic Sector Holds Firm.

Editor / Curator - January 8, 2023

Biotech News

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by FDA.

Editor / Curator - February 18, 2020

Latest article

IA Initiates Analyst Coverage of Principal Solar (Press Release).

Alternative Energy Editor / Curator - March 20, 2023

Principal Solar, Inc.Mon, March 20, 2023 at 7:30 AM EDT Institutional Analyst, Inc....

Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.

All News Editor / Curator - March 13, 2023

Going Short the Market. No Long Dissertation, No Rush. Market Risk Has Appeared, With Minimal Upside, So Time To Act.

We’re Bearish, but we’re up 257% in Provention Bio (PRVB) Today.

2022 Watch List Editor / Curator - March 13, 2023

And up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of...

The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062